Custom peptide synthesis enables researchers and product developers to obtain peptides manufactured according to a specific amino acid sequence, purity level, quantity and functional requirement. Unlike standard catalogue peptides, custom synthesis can incorporate terminal modifications, labels, non-natural amino acids, cyclization, conjugation and other structural features required for a particular experiment or development program.
Custom peptides are widely used in drug discovery, target validation, antibody production, diagnostic development, vaccines, biochemical assays, consumer health research and cosmetic formulation. PeptiOrigin provides synthesis services covering standard and structurally complex peptides, research-scale projects, peptide libraries and larger-volume manufacturing.
A peptide is a chain of amino acids connected by peptide bonds. In a custom synthesis project, the customer specifies the required amino acid sequence and the supplier develops an appropriate production, purification and analytical strategy.
A typical order may define:
Amino acid sequence;
N-terminal and C-terminal configuration;
Required purity;
Required quantity;
Salt form;
Chemical modifications;
Labeling or conjugation;
Packaging format;
Analytical documentation;
Intended research or commercial application.
The complexity of a project depends not only on peptide length. Hydrophobicity, aggregation tendency, amino acid composition, secondary structure, modification type and required purity can all affect synthesis yield and manufacturing difficulty.
Solid-phase peptide synthesis, commonly known as SPPS, is one of the most widely used methods for producing custom peptides. In SPPS, the growing peptide chain remains attached to an insoluble resin while amino acids are added sequentially. This makes it easier to remove excess reagents and by-products after each reaction cycle.
The process begins with a review of the requested sequence. The synthesis team evaluates:
Peptide length;
Hydrophobic and charged residues;
Repetitive amino acid regions;
Oxidation-sensitive residues;
Aggregation risk;
Potential side reactions;
Modification positions;
Solubility requirements;
Target purity and quantity.
A feasibility review is especially important for long, highly hydrophobic, cyclic or heavily modified peptides. Potential manufacturing difficulties can often be reduced by adjusting the synthesis strategy without changing the required biological function.
The first protected amino acid is attached to a solid resin. The selected resin influences the final C-terminal structure and may be chosen according to whether the required peptide ends with a free acid, amide or another functional group.
Protecting groups are used to prevent reactive side chains from participating in unwanted reactions during chain assembly.
Peptide chains are normally assembled through repeated deprotection and coupling cycles.
During each cycle:
The temporary protecting group is removed.
The resin is washed.
The next protected amino acid is activated.
The activated amino acid is coupled to the growing chain.
Excess reagents and reaction by-products are removed.
These steps continue until the full sequence has been assembled. Reaction conditions may be adjusted for difficult residues or regions prone to incomplete coupling.
After chain assembly, the peptide is cleaved from the resin. Remaining side-chain protecting groups are removed during or after this stage.
The resulting material is a crude peptide mixture that may contain:
Full-length target peptide;
Truncated sequences;
Deletion products;
Oxidized products;
Incompletely deprotected material;
Other synthesis-related impurities.
Purification is therefore required for most research and development applications.
Preparative high-performance liquid chromatography is commonly used to separate the target peptide from synthesis-related impurities.
Purification conditions are developed according to:
Peptide hydrophobicity;
Molecular weight;
Charge;
Solubility;
Target purity;
Quantity;
Stability under chromatographic conditions.
Highly hydrophobic peptides and peptides with similar impurity profiles may require additional method development or repeated purification.
The purified peptide is analyzed to confirm that it meets the agreed specifications. PeptiOrigin identifies HPLC or UPLC and mass spectrometry among the analytical methods used to evaluate peptide purity and identity.
Common quality-control documents include:
Analytical HPLC chromatogram;
Mass spectrometry report;
Certificate of analysis;
Peptide content or net peptide content;
Appearance;
Solubility information;
Water content;
Residual solvent data;
Counterion or salt-form information.
The required tests should be agreed before production because different applications require different levels of characterization.
After purification, the peptide is normally freeze-dried to obtain a powder. It can then be divided into one or multiple vials according to the customer’s experimental plan.
Aliquoting into smaller quantities can reduce repeated freeze-thaw cycles and exposure to moisture during laboratory use.
Higher purity generally requires more extensive purification and may reduce the final recovered yield. Therefore, the highest available purity is not always necessary for every application.
| Suggested Purity | Typical Application |
|---|---|
| Crude or desalted | Initial screening, method development and certain peptide-library projects |
| ≥70% | Preliminary antibody production and non-quantitative screening |
| ≥80% | General screening and exploratory biochemical studies |
| ≥90% | Many routine research assays |
| ≥95% | Cell-based assays, quantitative studies and binding experiments |
| ≥98% | Sensitive biological studies, analytical standards and advanced development |
| Up to 99% | Projects requiring very high purity and extensive analytical control |
PeptiOrigin states that its custom synthesis platform can provide purity levels up to 99%, subject to sequence feasibility and project requirements.
Purity percentage alone does not provide a complete quality assessment. Buyers should also confirm peptide identity, net peptide content, water content, residual solvents and the nature of remaining impurities.
Chemical modification can improve peptide stability, solubility, biological activity, detection or attachment to another molecule.
Common terminal options include:
N-terminal acetylation;
N-terminal formylation;
C-terminal amidation;
Free N-terminal amine;
Free C-terminal acid.
Acetylation and amidation are often used to mimic the terminal state of naturally occurring peptides or improve resistance to enzymatic degradation.
Fluorescent dyes can support peptide localization, binding studies, cellular uptake evaluation and imaging.
Possible labels include:
FITC;
FAM;
TAMRA;
Cy dyes;
Other application-specific fluorophores.
The labeling position and linker should be selected carefully because a bulky fluorescent group may affect binding or biological activity.
Biotin-labeled peptides are commonly used in:
Pull-down assays;
Binding studies;
Immobilization;
Detection systems;
Protein-interaction analysis.
Biotin can be introduced at the N-terminus, C-terminus or a selected side chain, with or without a spacer.
Custom synthesis can produce peptides containing modifications such as:
Phosphorylation;
Methylation;
Acetylation;
Sulfation;
Glycosylation-related structures;
Other residue-specific modifications.
Modified peptides are useful for studying signaling pathways, enzyme-substrate interactions and antibody specificity.
The incorporation of D-amino acids and other non-natural residues can help researchers investigate structure–activity relationships and improve metabolic stability, binding affinity or selectivity.
PeptiOrigin lists D-amino acids, fluorinated residues and other non-standard building blocks among its available customization capabilities.
PEG chains or lipid groups may be added to modify:
Solubility;
Circulation time;
Membrane interaction;
Cellular uptake;
Pharmacokinetic behavior.
These modifications require careful selection of the attachment position and linker structure.
A peptide can be conjugated to:
Carrier proteins;
Fluorescent dyes;
Biotin;
Polymers;
Lipids;
Drugs;
Nanoparticles;
Other peptides.
The conjugation method should preserve the function of both the peptide and the attached molecule.
Linear peptides are the most straightforward structural format. They are suitable for many assay, antigen, binding and screening applications.
However, some linear peptides may be susceptible to enzymatic degradation or may not maintain the conformation required for effective target binding.
Cyclization can restrict peptide flexibility and stabilize a biologically relevant conformation. It may also improve resistance to proteases.
Cyclization methods include:
Head-to-tail cyclization;
Side-chain-to-side-chain cyclization;
Head-to-side-chain cyclization;
Disulfide-bond formation;
Linker-based cyclization.
The synthesis strategy must define the cyclization position, bond type and required disulfide connectivity.
Stapled peptides contain a chemical bridge that stabilizes a selected secondary structure, often an alpha helix. This strategy may improve target affinity, structural stability or cellular uptake for suitable sequences.
PeptiOrigin’s synthesis and optimization capabilities include cyclic peptides, stapled peptides, disulfide formation and other structured peptide formats.
A peptide library contains a collection of related sequences designed for systematic biological testing.
Common library formats include:
Each residue is replaced individually with alanine to identify amino acids that are important for binding or biological activity.
A longer protein sequence is divided into partially overlapping peptide fragments. These libraries are commonly used for epitope mapping and protein-interaction studies.
Residues are progressively removed from one or both termini to identify the shortest active sequence.
A scrambled peptide contains the same or similar amino acid composition but a different sequence. It can serve as a negative control in biological studies.
Defined positions are systematically varied to examine sequence preferences and identify more active analogues.
PeptiOrigin offers peptide-library synthesis for high-throughput screening and structure–activity relationship studies, including positional scanning, alanine scanning, overlapping, truncation and scrambled libraries.
Custom peptide synthesis price is determined by several connected factors.
Longer peptides require more coupling cycles and generally present a higher risk of incomplete reactions, aggregation and yield loss.
Sequences may be more difficult when they contain:
Long hydrophobic regions;
Repeated residues;
Multiple cysteines;
Oxidation-sensitive amino acids;
Sterically hindered residues;
Aggregation-prone regions.
Higher purity normally requires more extensive purification, additional method development and greater starting material.
A milligram-scale research order and a multigram or kilogram-scale manufacturing project require different equipment, process controls and documentation.
Fluorescent labels, non-natural amino acids, cyclization, PEGylation and complex conjugation can increase raw-material cost and process complexity.
Additional tests, reference standards, stability studies and regulatory documentation may affect both price and delivery time.
For an accurate quotation, buyers should provide the full sequence and technical requirements instead of requesting a price based only on peptide length.
Scale-up is not simply a matter of multiplying the laboratory synthesis recipe. Larger production requires control of coupling efficiency, mixing, heat transfer, solvent use, purification loading and batch consistency.
A practical scale-up process usually includes:
Small-scale feasibility synthesis;
Identification of sequence-related risks;
Optimization of coupling and deprotection conditions;
Development of purification methods;
Confirmation of analytical methods;
Pilot-scale production;
Larger-batch manufacturing.
PeptiOrigin states that it supports projects from milligram quantities to multigram and kilogram-scale production, including research-grade and GMP-oriented manufacturing requirements.
To receive a technically useful quotation, provide:
Peptide sequence from N-terminus to C-terminus;
Required terminal groups;
Modification type and position;
Linear, cyclic or stapled structure;
Disulfide-bond pattern;
Required purity;
Required quantity;
Salt or counterion preference;
Packaging and aliquoting requirements;
Required analytical reports;
Intended application;
Desired delivery schedule;
Expected future scale.
For fluorescent, biotinylated or conjugated peptides, also specify the attachment position and whether a spacer is required.
PeptiOrigin lists synthesis capabilities for peptides ranging from two to more than 100 amino acids. Feasibility depends on sequence composition, modification requirements, structure and target purity.
Many difficult sequences can be produced through customized resin selection, coupling conditions, solvents, additives or fragment-based strategies. However, yield and purity should be evaluated through a feasibility study.
A purity of at least 95% is suitable for many biochemical and cell-based experiments. More sensitive quantitative, therapeutic or analytical applications may require 98% or higher purity.
Yes, but peptides with several cysteine residues require a defined disulfide-connectivity strategy. Selective protecting groups or stepwise oxidation may be necessary.
Common documents include an HPLC chromatogram, mass spectrometry report and certificate of analysis. Additional tests should be specified before quotation.
Yes. The total quantity can be divided into smaller aliquots to match experimental requirements and reduce repeated handling.
Storage conditions depend on the sequence and modification. Lyophilized peptides are generally protected from moisture and repeated temperature changes, while prepared solutions may require shorter storage periods and controlled freezing conditions. Model-specific storage recommendations should be confirmed with the supplier.
PeptiOrigin combines custom peptide synthesis with peptide design, structural optimization, library construction, high-throughput screening and targeted delivery development. Its platform supports linear and structured peptides, specialty modifications, high-purity purification and projects ranging from research quantities to larger-scale production.
To begin a project, submit the peptide sequence, required purity, quantity, modifications and intended application. A technical review can then determine the appropriate synthesis, purification and analytical strategy.
Latest Post
Blogs
Jul. 28, 2026
Step-by-Step Guide to Ordering Peptides Online
Ordering peptides online involves more than entering an amino acid sequence and selecting a quantity. The specifications you provide determine whether the peptide can be synthesized efficiently, whether it will work in your application and whether the final quotation covers all required modifications, purification and testing.
Blogs
Jul. 28, 2026
Complete Guide to Custom Peptide Synthesis
Custom peptide synthesis enables researchers and product developers to obtain peptides manufactured according to a specific amino acid sequence, purity level, quantity and functional requirement. Unlike standard catalogue peptides, custom synthesis can incorporate terminal modifications, labels, non-natural amino acids, cyclization, conjugation and
Blogs
Jul. 28, 2026
Peptide Stapling Service for Conformational Stabilization and Intracellular Target Modulation
Peptide Stapling Service is an advanced peptide engineering platform focused on stabilizing peptide secondary structures, particularly alpha-helices, to improve biological activity, metabolic stability, and cell permeability.
中文 
DE 
